MIB1 and familial pancreatic carcinoma: Importantly, high MIB1 expression levels in pancreatic cancer patients were associated with shorter overall survival by using The Human Protein Atlas (Fig. 1I), suggesting that aberrant MIB1 expression may represent a poor prognosis biomarker in pancreatic cancer.